Can blood-based markers predict RECIST progression in non-small cell lung cancer treated with immunotherapy?

Melda Yeghaian, Teresa M. Tareco Bucho, Melissa de Bruin, Alexander Schmitz, Zuhir Bodalal, Egbert F. Smit, Regina G.H. Beets-Tan, Daan van den Broek, Stefano Trebeschi*

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

Fingerprint

Dive into the research topics of 'Can blood-based markers predict RECIST progression in non-small cell lung cancer treated with immunotherapy?'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology